Immunovant, Inc. · NASDAQ:IMVT
Stout Jay S sold 3,487 Immunovant, Inc. shares (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Stout Jay S (Chief Technology Officer) sold 3,487 Immunovant, Inc. shares at an average US$39.55 for US$138K, leaving 208,198 shares. Filed Jul 10, 2026 (Form 4).
- Sold
- 3,487 shares
- Price
- US$39.55 average (US$39.53 to US$39.99)
- Value
- US$138K
- Holding after
- 208,198 shares
- Trading plan
- No
- Role
- Chief Technology Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Sale | 1,906 | US$39.53 | 209,779 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 105 | US$39.99 | 209,674 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 1,399 | US$39.53 | 208,275 | Direct |
| Jul 8, 2026 | Common Stock | Sale | 77 | US$39.99 | 208,198 | Direct |
Source
Related
- Immunovant, Inc.
- Stout Jay S
- Immunovant, Inc. shareholders
- Form 4 · Stout Jay S · Oct 9, 2026
- Form 4 · Stout Jay S · Jul 24, 2026
- Form 4 · Stout Jay S · Jun 26, 2026
- Form 4 · Stout Jay S · Apr 24, 2026
- Form 4 · Stout Jay S · Apr 10, 2026
- Form 4 · Gloria Melanie · Oct 9, 2026
- Form 4 · Van Tuyl Christopher · Oct 9, 2026
- Form 4 · Venker Eric · Oct 5, 2026
- Form 4 · Van Tuyl Christopher · Sep 25, 2026
- Form 4 · Pande Atul · Aug 28, 2026